(189628, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008943', 'increased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189629, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189630, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030153', 'dental pulp inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189631, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010050', 'hypermyelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189632, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031169', 'abnormal joint physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189633, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004142', 'abnormal muscle tone', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189634, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189635, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000920', 'abnormal myelination', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189636, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002128', 'abnormal blood circulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189637, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189638, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031130', 'right-to-left shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189639, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004782', 'abnormal surfactant physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189640, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189641, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031111', 'meningoencephalitis', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189642, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189643, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189644, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002841', 'impaired skeletal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189645, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012745', 'abnormal neural crest cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189646, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003484', 'abnormal channel response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189647, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189648, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005001', 'abnormal clonal deletion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189649, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010143', 'enhanced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189650, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011809', 'abnormal anoikis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189651, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010746', 'abnormal pre-Botzinger complex physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189652, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010071', 'abnormal pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189653, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189654, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189655, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003468', 'increased single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189656, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189657, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189658, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009348', 'abnormal urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189659, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003009', 'abnormal cytokine secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189660, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189661, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001636', 'irregular heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189662, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013640', 'increased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189663, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006335', 'abnormal hearing electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189664, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189665, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189666, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001916', 'intracerebral hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189667, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189668, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009567', 'mitotic nondisjunction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189669, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004144', 'hypotonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189670, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189671, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189672, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003901', 'abnormal PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189673, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013638', 'decreased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189674, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189675, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030924', 'early exit from telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189676, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189677, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001985', 'abnormal gustatory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189678, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020218', 'abnormal tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189679, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004994', 'abnormal brain wave pattern', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189680, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189681, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003008', 'enhanced long-term potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189682, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010393', 'shortened QRS complex duration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189683, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003824', 'decreased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189684, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005000', 'abnormal immune tolerance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189685, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000351', 'increased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189686, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011047', 'increased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189687, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004945', 'abnormal bone resorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189688, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004878', 'increased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189689, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003252', 'abnormal bile duct physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189690, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002826', 'tonic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189691, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189692, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006138', 'congestive heart failure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189693, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189694, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001500', 'decreased kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189695, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189696, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003488', 'decreased channel response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189697, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003485', 'abnormal channel response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189698, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008776', 'increased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189699, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010386', 'abnormal urinary bladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189700, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005037', 'mucous diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189701, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189702, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002914', 'abnormal endplate potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189703, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189704, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008744', 'abnormal B cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189705, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011930', 'abnormal tricuspid valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189706, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031098', 'abnormal sputum production', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189707, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031009', 'abnormal sperm-egg fusion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189708, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011805', 'decreased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189709, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001900', 'impaired synaptic plasticity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189710, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189711, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003699', 'abnormal female reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189712, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009358', 'environmentally induced seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189713, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189714, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001664', 'abnormal digestion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189715, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008748', 'abnormal central T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189716, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001924', 'infertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189717, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006265', 'increased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189718, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003823', 'increased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189719, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003476', 'decreased summary potential intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189720, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001629', 'abnormal heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189721, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003868', 'abnormal feces composition', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189722, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004768', 'abnormal axonal transport', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189723, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010560', 'intraventricular block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189724, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020137', 'decreased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189725, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031402', 'decreased muscle fatigability', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189726, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031014', 'polyspermy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189727, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003633', 'abnormal nervous system physiology', 0.6086956521739131, 7.291997705654976, 2.1068002513514026, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189728, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003725', 'increased autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189729, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012554', 'increased serum complement activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189730, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189731, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001542', 'abnormal bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189732, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011954', 'shortened PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189733, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005088', 'increased acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189734, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008272', 'abnormal endochondral bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189735, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002420', 'abnormal adaptive immunity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189736, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013644', 'increased vertebra maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189737, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189738, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189739, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189740, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189741, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020155', 'enhanced humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189742, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002164', 'abnormal gland physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189743, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010822', 'pneumothorax', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189744, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189745, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003477', 'abnormal nerve fiber response', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189746, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189747, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189748, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003216', 'absence seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189749, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189750, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002406', 'increased susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189751, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004010', 'increased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189752, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002987', 'abnormal urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189753, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000343', 'abnormal response to cardiac infarction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189754, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189755, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021016', 'decreased tau protein phosphorylation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189756, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003465', 'increased single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189757, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189758, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189759, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012504', 'increased forebrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189760, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189761, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006043', 'decreased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189762, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189763, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189764, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189765, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003077', 'abnormal cell cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189766, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189767, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011804', 'increased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189768, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021009', 'abnormal synaptic physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189769, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189770, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189771, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011951', 'increased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189772, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189773, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010653', 'abnormal Wallerian degeneration', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189774, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189775, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003259', 'nausea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189776, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189777, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001648', 'abnormal apoptosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189778, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005671', 'abnormal response to transplant', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189779, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189780, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004495', 'decreased synaptic glutamate release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189781, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189782, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005025', 'abnormal response to infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189783, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004211', 'abnormal sour taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189784, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010571', 'shortened ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189785, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021010', 'impaired synaptic physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189786, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001951', 'abnormal breathing pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189787, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031469', 'abnormal pinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189788, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004122', 'abnormal sinus arrhythmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189789, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005646', 'abnormal pituitary gland physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189790, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004859', 'abnormal synaptic plasticity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189791, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020846', 'abnormal cell motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189792, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031117', 'subdural hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189793, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011432', 'decreased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189794, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000751', 'myopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189795, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021083', 'increased cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189796, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010636', 'bundle branch block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189797, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003489', 'increased channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189798, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030941', 'enhanced autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189799, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010950', 'abnormal lung hysteresivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189800, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010634', 'increased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189801, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189802, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013806', 'encephalopathy', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189803, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001496', 'audiogenic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189804, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189805, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005167', 'abnormal blood-brain barrier function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189806, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001950', 'abnormal respiratory sounds', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189807, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189808, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189809, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000352', 'decreased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189810, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000313', 'abnormal cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189811, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189812, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013438', 'dysmyelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189813, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001752', 'abnormal hypothalamus secretion', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189814, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189815, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189816, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004877', 'abnormal systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189817, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004484', 'abnormal response of heart to induced stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189818, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004879', 'decreased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189819, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006052', 'cerebellum hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189820, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189821, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013641', 'increased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189822, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009645', 'crystalluria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189823, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001983', 'abnormal olfactory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189824, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001475', 'reduced long-term depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189825, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189826, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003997', 'tonic-clonic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189827, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000505', 'decreased digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189828, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005333', 'decreased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189829, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189830, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030132', 'periodontium inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189831, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031470', 'abnormal macropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189832, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003880', 'abnormal central pattern generator function', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189833, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011931', 'abnormal pulmonary valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189834, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013561', 'abnormal endocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189835, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189836, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003233', 'prolonged QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189837, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031126', 'gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189838, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011936', 'abnormal PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189839, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003866', 'abnormal defecation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189840, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002498', 'abnormal acute inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189841, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011900', 'podocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189842, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002338', 'abnormal pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189843, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008877', 'abnormal DNA methylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189844, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189845, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004558', 'delayed allantois development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189846, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008004', 'abnormal stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189847, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003897', 'abnormal ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189848, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189849, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009732', 'ventricular premature beat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189850, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003481', 'decreased nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189851, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003621', 'dysuria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189852, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011927', 'abnormal cardiac valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189853, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189854, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031128', 'cardiovascular shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189855, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030990', 'nerve inflammation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189856, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010553', 'prolonged HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189857, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189858, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189859, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001986', 'abnormal taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189860, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189861, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014254', 'increased paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189862, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000231', 'hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189863, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189864, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021026', 'decreased cerebrospinal fluid amyloid beta 40 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189865, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189866, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189867, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189868, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002322', 'abnormal respiratory transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189869, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189870, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020848', 'abnormal exocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189871, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189872, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189873, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189874, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003412', 'abnormal afterhyperpolarization', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189875, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003464', 'abnormal single cell response threshold', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189876, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031092', 'dysgeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189877, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010895', 'increased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189878, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008942', 'abnormal induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189879, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003298', 'choking', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189880, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189881, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002327', 'abnormal respiratory function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189882, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189883, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001598', 'abnormal blood viscosity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189884, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000951', 'sporadic seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189885, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010758', 'increased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189886, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014120', 'focal seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189887, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001634', 'internal hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189888, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005085', 'abnormal gallbladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189889, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189890, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189891, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189892, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012503', 'increased midbrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189893, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009141', 'increased prepulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189894, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011938', 'prolonged PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189895, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189896, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189897, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189898, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005575', 'increased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189899, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010954', 'abnormal cellular respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189900, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001876', 'decreased inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189901, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002694', 'abnormal pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189902, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010570', 'prolonged ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189903, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189904, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189905, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030991', 'optic nerve inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189906, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020371', 'abnormal glymphatic system physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189907, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010695', 'abnormal blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189908, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030214', 'muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189909, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189910, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002334', 'abnormal airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189911, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006058', 'decreased cerebral infarct size', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189912, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002292', 'abnormal gestational length', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189913, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003471', 'abnormal summary potential threshold', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189914, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008002', 'hyperchlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189915, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009562', 'abnormal odor adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189916, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003996', 'clonic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189917, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002421', 'abnormal cell-mediated immunity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189918, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189919, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002578', 'impaired ability to fire action potentials', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189920, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006002', 'abnormal small intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189921, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009698', 'heart hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189922, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012553', 'decreased serum complement activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189923, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002064', 'seizures', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189924, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001666', 'abnormal intestinal absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189925, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006080', 'brain ischemia', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189926, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001627', 'abnormal cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189927, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010946', 'hyperpnea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189928, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189929, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003741', 'tinnitus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189930, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002500', 'granulomatous inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189931, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189932, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006051', 'brainstem hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189933, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010520', 'sinoatrial block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189934, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010554', 'shortened HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189935, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189936, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001912', 'increased cerebrospinal fluid production', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189937, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002915', 'abnormal synaptic depression', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189938, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189939, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189940, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031090', 'ageusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189941, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005004', 'abnormal lymphocyte anergy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189942, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001963', 'abnormal hearing physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189943, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000327', 'hemosiderinuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189944, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010654', 'slow Wallerian degeneration', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189945, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005666', 'abnormal adipose tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189946, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030215', 'facial muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189947, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189948, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002409', 'decreased susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189949, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004156', 'abnormal QT variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189950, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189951, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189952, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010756', 'decreased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189953, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189954, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001846', 'increased inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189955, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003889', 'enhanced sensorimotor gating', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189956, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189957, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013136', 'genital discharge', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189958, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010519', 'atrioventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189959, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002328', 'abnormal airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189960, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009275', 'bruising', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189961, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189962, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013559', 'abnormal exocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189963, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013627', 'increased vertebra yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189964, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189965, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189966, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008003', 'achlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189967, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003726', 'decreased autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189968, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002193', 'minimal clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189969, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012201', 'decreased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189970, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002330', 'abnormal bronchial provocation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189971, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006336', 'abnormal otoacoustic response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189972, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004835', 'abnormal miniature endplate potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189973, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189974, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013637', 'increased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189975, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000243', 'myoclonus', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189976, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189977, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003927', 'increased cellular glucose import', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189978, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189979, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001934', 'increased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189980, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010504', 'abnormal RR interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189981, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008995', 'early reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189982, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013596', 'abnormal vomeronasal organ physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189983, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020097', 'low mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189984, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013625', 'increased femur yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189985, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189986, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011420', 'pyuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189987, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189988, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020001', 'decreased response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189989, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002161', 'abnormal fertility/fecundity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189990, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031480', 'abnormal urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189991, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(189992, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012556', 'increased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189993, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001790', 'abnormal immune system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189994, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189995, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005620', 'abnormal muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189996, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004212', 'abnormal salty taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189997, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189998, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(189999, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013145', 'eye discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190000, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003483', 'decreased nerve fiber response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190001, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001954', 'respiratory distress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190002, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190003, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190004, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190005, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010992', 'increased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190006, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003472', 'increased summary potential threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190007, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020424', 'increased kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190008, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006001', 'abnormal intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190009, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006054', 'spinal hemorrhage', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190010, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010752', 'impaired mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190011, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031088', 'coughing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190012, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002635', 'reduced sensorimotor gating', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190013, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190014, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008840', 'abnormal spike wave discharge', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190015, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004072', 'abnormal frontal plane axis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190016, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190017, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011068', 'abnormal ependyma motile cilium physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190018, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190019, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190020, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012685', 'abnormal primitive streak elongation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190021, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002499', 'chronic inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190022, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031110', 'meningitis', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190023, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009661', 'abnormal pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190024, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190025, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009046', 'muscle twitch', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190026, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190027, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001844', 'autoimmune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190028, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003777', 'lip inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190029, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014178', 'increased brain apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190030, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003875', 'abnormal hair follicle regression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190031, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003219', 'increased spike-wave discharge type II', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190032, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190033, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190034, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004085', 'abnormal heartbeat', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190035, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020381', 'muscle gating pore current', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190036, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190037, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011920', 'abnormal S wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190038, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003925', 'abnormal cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190039, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003475', 'increased summary potential intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190040, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190041, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020096', 'high mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190042, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004751', 'increased length of allograft survival', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190043, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190044, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030951', 'abnormal endocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190045, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010515', 'abnormal Q wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190046, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031306', 'abnormal cartilage physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190047, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190048, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013632', 'increased femur maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190049, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008814', 'decreased nerve conduction velocity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190050, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004781', 'abnormal surfactant composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190051, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005076', 'abnormal cell differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190052, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008568', 'abnormal interleukin secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190053, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014179', 'abnormal blood-retina barrier function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190054, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190055, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001943', 'abnormal respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190056, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001919', 'abnormal reproductive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190057, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190058, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020414', 'abnormal fibroblast physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190059, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010637', 'sinus bradycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190060, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190061, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190062, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021025', 'increased cerebrospinal fluid amyloid beta 40 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190063, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008861', 'abnormal hair shedding', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190064, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010896', 'decreased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190065, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190066, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013135', 'poor circulation in tail', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190067, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014275', 'increased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190068, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002133', 'abnormal respiratory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190069, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002917', 'decreased synaptic depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190070, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003566', 'abnormal cell adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190071, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004213', 'abnormal umami taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190072, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190073, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011399', 'increased endoneurial fluid pressure', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190074, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020138', 'delayed bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190075, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012197', 'impaired myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190076, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004780', 'abnormal surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190077, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002472', 'impaired complement alternative pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190078, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190079, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031221', 'abnormal CXCL10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190080, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001917', 'intraventricular hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190081, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003394', 'increased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190082, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031109', 'subarachnoid hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190083, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001663', 'abnormal digestive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190084, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003292', 'melena', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190085, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004143', 'muscle hypertonia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190086, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190087, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010559', 'heart block', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190088, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190089, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010073', 'decreased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190090, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003186', 'abnormal redox activity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190091, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190092, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001835', 'abnormal antigen presentation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190093, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190094, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020845', 'abnormal DNA-templated transcription', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190095, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031013', 'abnormal egg activation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190096, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003470', 'abnormal summary potential', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190097, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190098, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001761', 'abnormal urination pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190099, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001473', 'reduced long-term potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190100, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004752', 'decreased length of allograft survival', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190101, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001845', 'abnormal inflammatory response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190102, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190103, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003116', 'rickets', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190104, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012502', 'decreased hindbrain apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190105, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190106, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004145', 'abnormal muscle electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190107, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030216', 'tongue muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190108, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003878', 'abnormal ear physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190109, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190110, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006114', 'cardiac murmur', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190111, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006266', 'decreased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190112, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190113, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190114, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001909', 'reduced NMDA receptor mediated synaptic activity in barrel cortex', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190115, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030938', 'abnormal reticulophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190116, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005435', 'hemoperitoneum', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190117, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190118, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011929', 'abnormal aortic valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190119, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003674', 'oxidative stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190120, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009045', 'muscle tetany', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190121, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014255', 'increased paired-pulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190122, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190123, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011418', 'leukocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190124, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001921', 'reduced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190125, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190126, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009643', 'abnormal urine homeostasis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190127, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003900', 'shortened QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190128, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031091', 'hypogeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190129, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001945', 'bronchoconstriction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190130, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013557', 'abnormal merocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190131, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003990', 'decreased neurotransmitter release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190132, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011928', 'abnormal mitral valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190133, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190134, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003490', 'decreased channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190135, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020039', 'increased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190136, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003096', 'increased corneal light-scattering', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190137, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190138, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190139, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190140, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002922', 'decreased post-tetanic potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190141, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031425', 'enhanced male fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190142, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021015', 'increased tau protein phosphorylation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190143, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031105', 'rhonchi', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190144, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020080', 'increased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190145, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190146, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004415', 'abnormal cochlear nerve compound action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190147, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012565', 'perivasculitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190148, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190149, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021001', 'impaired neuron physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190150, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031089', 'sneezing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190151, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020002', 'increased response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190152, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011194', 'abnormal hair follicle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190153, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190154, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010513', 'abnormal ventricular activation time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190155, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010155', 'abnormal intestine physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190156, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190157, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190158, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008558', 'abnormal interferon-beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190159, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190160, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190161, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190162, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011044', 'increased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190163, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005501', 'abnormal skin physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190164, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002998', 'abnormal bone remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190165, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020040', 'decreased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190166, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190167, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190168, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006088', 'abnormal blood-cerebrospinal fluid barrier function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190169, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190170, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190171, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006003', 'abnormal large intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190172, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000316', 'cellular necrosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190173, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001533', 'abnormal skeleton physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190174, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000738', 'impaired muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190175, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190176, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001935', 'decreased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190177, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004759', 'decreased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190178, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002896', 'abnormal bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190179, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008006', 'increased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190180, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190181, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001914', 'hemorrhage', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190182, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002916', 'increased synaptic depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190183, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005036', 'diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190184, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004046', 'abnormal mitosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190185, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005576', 'decreased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190186, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190187, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002842', 'increased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190188, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190189, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190190, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014274', 'decreased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190191, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031471', 'abnormal micropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190192, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011952', 'decreased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190193, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020147', 'abnormal defecation amount', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190194, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002693', 'abnormal pancreas physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190195, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010368', 'abnormal lymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190196, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003926', 'decreased cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190197, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004036', 'abnormal muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190198, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014030', 'abnormal mucous gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190199, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190200, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010514', 'fragmented QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190201, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011421', 'cylindruria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190202, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003690', 'abnormal glial cell physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190203, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005410', 'abnormal fertilization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190204, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014253', 'decreased paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190205, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005551', 'abnormal eye electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190206, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008544', 'impaired olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190207, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012261', 'increased hindbrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190208, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190209, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190210, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013134', 'poor circulation in autopods', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190211, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006324', 'abnormal cochlear nerve fiber response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190212, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005403', 'abnormal nerve conduction', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190213, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003466', 'decreased single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190214, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001793', 'abnormal susceptibility to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190215, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020154', 'impaired humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190216, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190217, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000948', 'nonconvulsive seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190218, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004037', 'increased muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190219, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006190', 'retina ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190220, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010072', 'increased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190221, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000947', 'convulsive seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190222, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030988', 'dysosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190223, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010394', 'decreased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190224, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002634', 'abnormal sensorimotor gating', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190225, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008747', 'abnormal T cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190226, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190227, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031102', 'rhinorrhea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190228, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190229, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004149', 'increased bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190230, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004760', 'increased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190231, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190232, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011043', 'abnormal lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190233, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012011', 'febrile seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190234, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010753', 'improved mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190235, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001933', 'abnormal litter size', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190236, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190237, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190238, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190239, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008007', 'abnormal cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190240, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009344', 'abnormal ovulation cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190241, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003473', 'decreased summary potential threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190242, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003899', 'abnormal QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190243, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002090', 'abnormal vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190244, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005043', 'defective assembly of class II molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190245, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003393', 'decreased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190246, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001596', 'hypotension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190247, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002195', 'psychomotor seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190248, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004513', 'avnosmia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190249, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190250, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031086', 'wheezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190251, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190252, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008005', 'decreased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190253, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190254, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190255, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003480', 'increased nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190256, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014046', 'abnormal mitophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190257, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008555', 'abnormal interferon secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190258, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002626', 'increased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190259, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030939', 'abnormal autophagosome formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190260, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011919', 'abnormal R wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190261, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005621', 'abnormal cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190262, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003217', 'increased spike-wave discharge type I', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190263, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031104', 'crackles', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190264, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190265, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003011', 'delayed dark adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190266, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190267, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008722', 'abnormal chemokine secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190268, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190269, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190270, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031302', 'syncope', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190271, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006082', 'CNS inflammation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190272, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000503', 'excessive digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190273, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010377', 'abnormal gut flora balance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190274, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190275, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190276, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001984', 'abnormal olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190277, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190278, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008921', 'increased neurotransmitter release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190279, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002106', 'abnormal muscle physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190280, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013752', 'stridor', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190281, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013475', 'delayed reproductive senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190282, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012111', 'failure of morula compaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190283, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000423', 'delayed hair regrowth', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190284, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031127', 'dry gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190285, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001847', 'brain inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190286, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003635', 'abnormal synaptic transmission', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190287, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001915', 'intracranial hemorrhage', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190288, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190289, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005005', 'abnormal self tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190290, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008008', 'early cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190291, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003202', 'abnormal neuron apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190292, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190293, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190294, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009473', 'abnormal skin exfoliation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190295, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009697', 'abnormal copulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190296, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001665', 'chronic diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190297, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013182', 'increased spinal cord apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190298, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190299, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190300, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013639', 'decreased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190301, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002471', 'abnormal complement pathway', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190302, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000427', 'abnormal hair cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190303, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190304, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009247', 'meteorism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190305, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190306, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000921', 'demyelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190307, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003928', 'increased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190308, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008260', 'abnormal autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190309, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003882', 'abnormal pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190310, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012200', 'increased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190311, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190312, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013636', 'abnormal bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190313, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031129', 'left-to-right shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190314, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000743', 'muscle spasm', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190315, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010381', 'abnormal dosage compensation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190316, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190317, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003762', 'abnormal immune organ physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190318, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009062', 'impaired lectin complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190319, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004070', 'abnormal P wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190320, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013555', 'abnormal apocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190321, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190322, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190323, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020412', 'abnormal amnion physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190324, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003122', 'maternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190325, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005087', 'decreased acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190326, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010028', 'aciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190327, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008817', 'hematoma', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190328, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000501', 'abnormal digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190329, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003547', 'abnormal pulmonary pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190330, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011082', 'abnormal gastrointestinal motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190331, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003261', 'hematemesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190332, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011925', 'abnormal heart echocardiography feature', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190333, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010994', 'aerophagia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190334, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003487', 'increased channel response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190335, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001899', 'absent long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190336, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008950', 'ventricular tachycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190337, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190338, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003474', 'abnormal summary potential intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190339, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190340, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002419', 'abnormal innate immunity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190341, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002136', 'abnormal kidney physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190342, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003469', 'decreased single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190343, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011918', 'abnormal PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190344, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030987', 'spinal cord inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190345, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012120', 'trophectoderm cell degeneration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190346, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003929', 'decreased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190347, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030129', 'tongue inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190348, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001499', 'abnormal kindling response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190349, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000740', 'impaired smooth muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190350, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190351, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0031424', 'enhanced female fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190352, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003280', 'urinary incontinence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190353, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010993', 'decreased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190354, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003467', 'abnormal single cell response intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190355, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003486', 'abnormal channel response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190356, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003260', 'vomiting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190357, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003898', 'abnormal QRS complex', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190358, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190359, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003482', 'increased nerve fiber response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190360, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010957', 'abnormal aerobic respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190361, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190362, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003157', 'impaired muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190363, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005044', 'sepsis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190364, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003787', 'abnormal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190365, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190366, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004011', 'decreased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190367, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002999', 'abnormal bone healing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190368, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013971', 'blood in lymph vessels', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190369, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011046', 'abnormal lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190370, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008271', 'abnormal bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190371, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001947', 'abnormal mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190372, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190373, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190374, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190375, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190376, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010552', 'abnormal HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190377, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0004811', 'abnormal neuron physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190378, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013634', 'increased femur fracture load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190379, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021013', 'abnormal synaptic vesicle endocytosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190380, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011953', 'prolonged PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190381, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0005532', 'abnormal vascular resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190382, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006049', 'semilunar valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190383, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0012555', 'decreased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190384, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0013556', 'abnormal holocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190385, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002333', 'abnormal lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190386, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0000350', 'abnormal cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190387, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0002723', 'abnormal immune serum protein physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190388, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010505', 'abnormal T wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190389, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0001898', 'abnormal long-term depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190390, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003820', 'increased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190391, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003123', 'paternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190392, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190393, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008775', 'abnormal heart ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190394, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011397', 'endoneurial edema', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190395, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190396, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0021084', 'decreased cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190397, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190398, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0009142', 'decreased prepulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190399, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003698', 'abnormal male reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190400, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011994', 'increased nerve conduction velocity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190401, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011518', 'abnormal cell chemotaxis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190402, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0014132', 'abnormal tear film physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190403, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190404, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0030940', 'impaired autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190405, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0011048', 'decreased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190406, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(190407, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190408, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0006046', 'atrioventricular valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190409, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020000', 'abnormal response to antigen', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190410, 'HP:0002071', 'Abnormality of extrapyramidal motor function', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190411, 'HP:0040295', 'Duplication of the upper lip', 'MP:0030168', 'thin upper lip', 0.4153846153846154, 11.852259765747807, 2.218838967621063, 'UPHENO:0087554', 'abnormal upper lip morphology'),
(190412, 'HP:0040295', 'Duplication of the upper lip', 'MP:0031503', 'abnormal mouth size', 0.4107142857142857, 7.503859459499253, 1.7555461480714831, 'UPHENO:0076800', 'abnormal mouth morphology'),
(190413, 'HP:0040295', 'Duplication of the upper lip', 'MP:0003782', 'short lip', 0.4098360655737705, 11.249595263293193, 2.147205128068906, 'UPHENO:0020955', 'abnormal lip morphology'),
(190414, 'HP:0040295', 'Duplication of the upper lip', 'MP:0009553', 'fused lips', 0.4153846153846154, 11.852259765747807, 2.218838967621063, 'UPHENO:0087554', 'abnormal upper lip morphology'),
(190415, 'HP:0040295', 'Duplication of the upper lip', 'MP:0003774', 'thick lip', 0.4032258064516129, 11.249595263293193, 2.129818565581501, 'UPHENO:0020955', 'abnormal lip morphology'),
(190416, 'HP:0040295', 'Duplication of the upper lip', 'MP:0003773', 'eclabion', 0.43103448275862066, 11.249595263293193, 2.2020362112275564, 'UPHENO:0020955', 'abnormal lip morphology'),
(190417, 'HP:0040295', 'Duplication of the upper lip', 'MP:0009576', 'oral atresia', 0.40350877192982454, 7.503859459499253, 1.7400784796199684, 'UPHENO:0076800', 'abnormal mouth morphology'),
(190418, 'HP:0040295', 'Duplication of the upper lip', 'MP:0012523', 'abnormal upper lip morphology', 0.4107142857142857, 11.852259765747807, 2.2063300758928337, 'UPHENO:0087554', 'abnormal upper lip morphology'),
(190419, 'HP:0040295', 'Duplication of the upper lip', 'MP:0003776', 'lip atrophy', 0.4166666666666667, 11.249595263293193, 2.1650245633030347, 'UPHENO:0020955', 'abnormal lip morphology'),
(190420, 'HP:0040295', 'Duplication of the upper lip', 'MP:0003771', 'abnormal lip shape', 0.4166666666666667, 11.249595263293193, 2.1650245633030347, 'UPHENO:0020955', 'abnormal lip morphology'),
(190421, 'HP:0040295', 'Duplication of the upper lip', 'MP:0003783', 'tented upper lip', 0.40350877192982454, 11.852259765747807, 2.1868906654586477, 'UPHENO:0087554', 'abnormal upper lip morphology'),
(190422, 'HP:0040295', 'Duplication of the upper lip', 'MP:0030169', 'thick upper lip', 0.4090909090909091, 11.852259765747807, 2.201965422605763, 'UPHENO:0087554', 'abnormal upper lip morphology'),
(190423, 'HP:0040295', 'Duplication of the upper lip', 'MP:0009881', 'increased mouth size', 0.40350877192982454, 7.503859459499253, 1.7400784796199684, 'UPHENO:0076800', 'abnormal mouth morphology'),
(190424, 'HP:0040295', 'Duplication of the upper lip', 'MP:0003775', 'thin lip', 0.4098360655737705, 11.249595263293193, 2.147205128068906, 'UPHENO:0020955', 'abnormal lip morphology'),
(190425, 'HP:0004599', 'Absent or minimally ossified vertebral bodies', 'MP:0004669', 'enlarged vertebral body', 0.41304347826086957, 8.941811350726098, 1.9218108289466038, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(190426, 'HP:0004599', 'Absent or minimally ossified vertebral bodies', 'MP:0000459', 'abnormal presacral vertebrae morphology', 0.4146341463414634, 8.941811350726098, 1.9255078073471226, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(190427, 'HP:0004599', 'Absent or minimally ossified vertebral bodies', 'MP:0021136', 'abnormal vertebrae shape', 0.4222222222222222, 8.941811350726098, 1.943046952390874, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(190428, 'HP:0004599', 'Absent or minimally ossified vertebral bodies', 'MP:0004610', 'small vertebrae', 0.4318181818181818, 8.941811350726098, 1.9650029820923236, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(190429, 'HP:0004599', 'Absent or minimally ossified vertebral bodies', 'MP:0004670', 'small vertebral body', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(190430, 'HP:0004599', 'Absent or minimally ossified vertebral bodies', 'MP:0000137', 'abnormal vertebrae morphology', 0.41025641025641024, 8.941811350726098, 1.9153160120301067, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(190431, 'HP:0004599', 'Absent or minimally ossified vertebral bodies', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.41304347826086957, 8.941811350726098, 1.9218108289466038, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(190432, 'HP:0004599', 'Absent or minimally ossified vertebral bodies', 'MP:0004626', 'vertebral compression', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(190433, 'HP:0001060', 'Axillary pterygium', 'MP:0002932', 'abnormal joint morphology', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190434, 'HP:0001060', 'Axillary pterygium', 'MP:0002060', 'abnormal skin morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(190435, 'HP:0003993', 'Broad ulna', 'MP:0030886', 'decreased radius size', 0.41025641025641024, 10.120647406075808, 2.037660539512779, 'UPHENO:0087349', 'abnormal forelimb zeugopod morphology'),
(190436, 'HP:0003993', 'Broad ulna', 'MP:0004370', 'long ulna', 0.4625, 15.192109768632433, 2.6507264604241043, 'UPHENO:0001330', 'increased size of the ulna'),
(190437, 'HP:0003993', 'Broad ulna', 'MP:0030901', 'increased ulna size', 0.5068493150684932, 15.192109768632433, 2.774907283257715, 'UPHENO:0001330', 'increased size of the ulna'),
(190438, 'HP:0003993', 'Broad ulna', 'MP:0030885', 'increased radius size', 0.4533333333333333, 10.120647406075808, 2.1419679792395825, 'UPHENO:0087349', 'abnormal forelimb zeugopod morphology'),
(190439, 'HP:0003993', 'Broad ulna', 'MP:0008163', 'increased diameter of ulna', 0.49333333333333335, 15.192109768632433, 2.7376585164197036, 'UPHENO:0001330', 'increased size of the ulna'),
(190440, 'HP:0003993', 'Broad ulna', 'MP:0008161', 'increased diameter of radius', 0.44155844155844154, 10.120647406075808, 2.1139671937353515, 'UPHENO:0087349', 'abnormal forelimb zeugopod morphology'),
(190441, 'HP:0003993', 'Broad ulna', 'MP:0008157', 'decreased diameter of ulna', 0.43037974683544306, 12.237913458245556, 2.294983680977663, 'UPHENO:0020868', 'abnormal ulna morphology'),
(190442, 'HP:0003993', 'Broad ulna', 'MP:0030900', 'decreased ulna size', 0.44155844155844154, 12.237913458245556, 2.324597598413537, 'UPHENO:0020868', 'abnormal ulna morphology'),
(190443, 'HP:0003993', 'Broad ulna', 'MP:0008951', 'long radius', 0.4146341463414634, 10.120647406075808, 2.0485033555357406, 'UPHENO:0087349', 'abnormal forelimb zeugopod morphology'),
(190444, 'HP:0003321', 'Biconcave flattened vertebrae', 'MP:0004626', 'vertebral compression', 0.41509433962264153, 8.941811350726098, 1.9265760503182556, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(190445, 'HP:0003321', 'Biconcave flattened vertebrae', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.4230769230769231, 8.941811350726098, 1.9450126048433474, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(190446, 'HP:0003321', 'Biconcave flattened vertebrae', 'MP:0008771', 'elongated vertebral column', 0.40384615384615385, 8.557298718460714, 1.85898686782962, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(190447, 'HP:0003321', 'Biconcave flattened vertebrae', 'MP:0021136', 'abnormal vertebrae shape', 0.43137254901960786, 8.941811350726098, 1.963988786937232, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(190448, 'HP:0002758', 'Osteoarthritis', 'MP:0030877', 'abnormal symphysis morphology', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190449, 'HP:0002758', 'Osteoarthritis', 'MP:0031350', 'polyostotic fibrous dysplasia', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190450, 'HP:0002758', 'Osteoarthritis', 'MP:0006430', 'abnormal elastic cartilage morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190451, 'HP:0002758', 'Osteoarthritis', 'MP:0006431', 'abnormal fibrocartilage morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190452, 'HP:0002758', 'Osteoarthritis', 'MP:0030805', 'abnormal limb joint morphology', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190453, 'HP:0002758', 'Osteoarthritis', 'MP:0011642', 'abnormal bone collagen fibril morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190454, 'HP:0002758', 'Osteoarthritis', 'MP:0004508', 'abnormal pectoral girdle bone morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190455, 'HP:0002758', 'Osteoarthritis', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190456, 'HP:0002758', 'Osteoarthritis', 'MP:0003795', 'abnormal bone structure', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190457, 'HP:0002758', 'Osteoarthritis', 'MP:0000566', 'synostosis', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190458, 'HP:0002758', 'Osteoarthritis', 'MP:0000163', 'abnormal cartilage morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190459, 'HP:0002758', 'Osteoarthritis', 'MP:0010970', 'abnormal compact bone lamellar structure', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190460, 'HP:0002758', 'Osteoarthritis', 'MP:0004509', 'abnormal pelvic girdle bone morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190461, 'HP:0002758', 'Osteoarthritis', 'MP:0005504', 'abnormal ligament morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190462, 'HP:0002758', 'Osteoarthritis', 'MP:0010924', 'abnormal osteoid morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190463, 'HP:0002758', 'Osteoarthritis', 'MP:0009877', 'exostosis', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190464, 'HP:0002758', 'Osteoarthritis', 'MP:0013941', 'abnormal enthesis morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190465, 'HP:0002758', 'Osteoarthritis', 'MP:0002937', 'synovial hyperemia', 0.4642857142857143, 8.414032639097075, 1.9764906156788347, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190466, 'HP:0002758', 'Osteoarthritis', 'MP:0000164', 'abnormal cartilage development', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190467, 'HP:0002758', 'Osteoarthritis', 'MP:0002657', 'chondrodystrophy', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190468, 'HP:0002758', 'Osteoarthritis', 'MP:0030819', 'abnormal pelvic girdle joint morphology', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190469, 'HP:0002758', 'Osteoarthritis', 'MP:0030818', 'abnormal girdle joint morphology', 0.48148148148148145, 8.414032639097075, 2.01275952371514, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190470, 'HP:0002758', 'Osteoarthritis', 'MP:0030484', 'abnormal osteocyte lacuna morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190471, 'HP:0002758', 'Osteoarthritis', 'MP:0012072', 'decreased susceptibility to osteoporosis', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190472, 'HP:0002758', 'Osteoarthritis', 'MP:0004625', 'abnormal rib joint morphology', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190473, 'HP:0002758', 'Osteoarthritis', 'MP:0008151', 'increased diameter of long bones', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190474, 'HP:0002758', 'Osteoarthritis', 'MP:0010971', 'abnormal periosteum morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190475, 'HP:0002758', 'Osteoarthritis', 'MP:0030878', 'abnormal fibrous joint morphology', 0.48148148148148145, 8.414032639097075, 2.01275952371514, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190476, 'HP:0002758', 'Osteoarthritis', 'MP:0010874', 'abnormal bone volume', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190477, 'HP:0002758', 'Osteoarthritis', 'MP:0030866', 'abnormal synovial joint membrane morphology', 0.4482758620689655, 8.414032639097075, 1.9421142434902365, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190478, 'HP:0002758', 'Osteoarthritis', 'MP:0014025', 'decreased subchondral bone mineral content', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190479, 'HP:0002758', 'Osteoarthritis', 'MP:0009807', 'abnormal pelvic ligament morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190480, 'HP:0002758', 'Osteoarthritis', 'MP:0002932', 'abnormal joint morphology', 0.52, 8.414032639097075, 2.091721055095655, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190481, 'HP:0002758', 'Osteoarthritis', 'MP:0010124', 'decreased bone mineral content', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190482, 'HP:0002758', 'Osteoarthritis', 'MP:0000130', 'abnormal trabecular bone morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190483, 'HP:0002758', 'Osteoarthritis', 'MP:0002113', 'abnormal skeleton development', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190484, 'HP:0002758', 'Osteoarthritis', 'MP:0010931', 'abnormal trabecular bone connectivity density', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190485, 'HP:0002758', 'Osteoarthritis', 'MP:0031349', 'monostotic fibrous dysplasia', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190486, 'HP:0002758', 'Osteoarthritis', 'MP:0003797', 'abnormal compact bone morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190487, 'HP:0002758', 'Osteoarthritis', 'MP:0004624', 'abnormal thoracic cage morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190488, 'HP:0002758', 'Osteoarthritis', 'MP:0030865', 'abnormal synovial joint cavity morphology', 0.4482758620689655, 8.414032639097075, 1.9421142434902365, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190489, 'HP:0002758', 'Osteoarthritis', 'MP:0030804', 'abnormal synovial joint morphology', 0.48148148148148145, 8.414032639097075, 2.01275952371514, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190490, 'HP:0002758', 'Osteoarthritis', 'MP:0030879', 'abnormal syndesmosis morphology', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190491, 'HP:0002758', 'Osteoarthritis', 'MP:0006429', 'abnormal hyaline cartilage morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190492, 'HP:0002758', 'Osteoarthritis', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190493, 'HP:0002758', 'Osteoarthritis', 'MP:0013629', 'abnormal bone trabecular spacing', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190494, 'HP:0002758', 'Osteoarthritis', 'MP:0030222', 'hyperostosis', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190495, 'HP:0002758', 'Osteoarthritis', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190496, 'HP:0002758', 'Osteoarthritis', 'MP:0030486', 'abnormal osteocyte canaliculus morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190497, 'HP:0002758', 'Osteoarthritis', 'MP:0005422', 'osteosclerosis', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190498, 'HP:0002758', 'Osteoarthritis', 'MP:0003200', 'calcified joint', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190499, 'HP:0002758', 'Osteoarthritis', 'MP:0003723', 'abnormal long bone morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190500, 'HP:0002758', 'Osteoarthritis', 'MP:0005508', 'abnormal skeleton morphology', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190501, 'HP:0002758', 'Osteoarthritis', 'MP:0000997', 'abnormal synovial joint capsule morphology', 0.4482758620689655, 8.414032639097075, 1.9421142434902365, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190502, 'HP:0002758', 'Osteoarthritis', 'MP:0010966', 'abnormal compact bone area', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190503, 'HP:0002758', 'Osteoarthritis', 'MP:0009918', 'abnormal stylohyoid ligament morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190504, 'HP:0002758', 'Osteoarthritis', 'MP:0004703', 'abnormal vertebral column morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190505, 'HP:0002758', 'Osteoarthritis', 'MP:0014024', 'increased subchondral bone mineral content', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190506, 'HP:0002758', 'Osteoarthritis', 'MP:0010119', 'abnormal bone mineral density', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190507, 'HP:0002758', 'Osteoarthritis', 'MP:0008150', 'decreased diameter of long bones', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190508, 'HP:0002758', 'Osteoarthritis', 'MP:0010925', 'abnormal osteoid volume', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190509, 'HP:0002758', 'Osteoarthritis', 'MP:0010122', 'abnormal bone mineral content', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190510, 'HP:0002758', 'Osteoarthritis', 'MP:0013304', 'osteophytes', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190511, 'HP:0002758', 'Osteoarthritis', 'MP:0031348', 'bone fibrous dysplasia', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190512, 'HP:0002758', 'Osteoarthritis', 'MP:0030875', 'abnormal cartilaginous joint morphology', 0.48148148148148145, 8.414032639097075, 2.01275952371514, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190513, 'HP:0002758', 'Osteoarthritis', 'MP:0010123', 'increased bone mineral content', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190514, 'HP:0002758', 'Osteoarthritis', 'MP:0002114', 'abnormal axial skeleton morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190515, 'HP:0002758', 'Osteoarthritis', 'MP:0012071', 'increased susceptibility to osteoporosis', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(190516, 'HP:0002758', 'Osteoarthritis', 'MP:0030795', 'joint dislocation', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190517, 'HP:0002758', 'Osteoarthritis', 'MP:0030820', 'abnormal pectoral girdle joint morphology', 0.40625, 8.414032639097075, 1.8488376780110218, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(190518, 'HP:0031507', 'Decreased circulating T4 concentration', 'MP:0002876', 'abnormal thyroid gland physiology', 0.40476190476190477, 12.548253578857707, 2.2536758906315333, 'UPHENO:0002325', 'abnormality of thyroid gland physiology'),
(190519, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190520, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190521, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190522, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190523, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190524, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190525, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190526, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190527, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190528, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190529, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190530, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190531, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190532, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190533, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190534, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190535, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190536, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190537, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190538, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190539, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190540, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190541, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190542, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190543, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190544, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190545, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190546, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190547, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190548, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190549, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190550, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190551, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190552, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190553, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190554, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190555, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190556, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190557, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190558, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190559, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190560, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190561, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190562, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190563, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190564, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190565, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190566, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190567, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190568, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190569, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190570, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190571, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190572, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190573, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190574, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190575, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190576, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190577, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190578, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190579, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190580, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190581, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190582, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190583, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190584, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190585, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190586, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190587, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190588, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190589, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190590, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190591, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190592, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190593, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190594, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190595, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190596, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190597, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190598, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190599, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190600, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190601, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190602, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190603, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190604, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190605, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190606, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190607, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190608, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190609, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190610, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190611, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190612, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190613, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190614, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190615, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190616, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190617, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190618, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190619, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190620, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190621, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190622, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190623, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190624, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190625, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190626, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190627, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190628, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190629, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190630, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190631, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190632, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190633, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190634, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190635, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190636, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190637, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190638, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190639, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190640, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190641, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190642, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190643, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190644, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190645, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190646, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190647, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190648, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190649, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190650, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190651, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190652, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190653, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190654, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190655, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190656, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190657, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190658, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190659, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190660, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190661, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190662, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190663, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190664, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190665, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190666, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190667, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190668, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190669, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190670, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190671, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190672, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190673, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190674, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190675, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190676, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190677, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190678, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190679, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190680, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190681, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190682, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190683, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190684, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190685, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190686, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190687, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190688, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190689, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190690, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190691, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190692, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190693, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190694, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190695, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190696, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190697, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190698, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190699, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190700, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190701, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190702, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190703, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190704, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190705, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190706, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190707, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190708, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190709, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190710, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190711, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190712, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190713, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190714, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190715, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190716, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190717, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190718, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190719, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190720, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190721, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190722, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190723, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190724, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190725, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190726, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190727, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190728, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190729, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190730, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190731, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190732, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190733, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190734, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190735, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190736, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190737, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190738, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190739, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190740, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190741, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190742, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190743, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190744, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190745, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190746, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190747, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190748, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190749, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190750, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190751, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190752, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190753, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190754, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190755, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190756, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190757, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190758, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190759, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190760, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190761, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190762, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190763, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190764, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190765, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190766, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190767, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190768, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190769, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190770, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190771, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190772, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190773, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190774, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190775, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190776, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190777, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190778, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190779, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190780, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190781, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190782, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190783, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190784, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190785, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190786, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190787, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190788, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190789, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190790, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190791, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190792, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190793, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190794, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190795, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190796, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190797, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190798, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190799, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190800, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190801, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190802, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190803, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190804, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190805, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190806, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190807, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190808, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190809, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190810, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190811, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190812, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190813, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190814, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190815, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190816, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190817, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190818, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190819, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190820, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190821, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190822, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190823, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190824, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190825, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190826, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190827, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190828, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190829, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190830, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190831, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190832, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190833, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190834, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190835, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190836, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190837, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190838, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190839, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190840, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190841, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190842, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190843, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190844, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190845, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190846, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190847, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190848, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190849, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190850, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190851, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190852, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190853, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190854, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190855, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190856, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190857, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190858, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190859, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190860, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190861, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190862, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190863, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190864, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190865, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190866, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190867, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190868, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190869, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190870, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190871, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190872, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190873, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190874, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190875, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190876, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190877, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190878, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190879, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190880, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190881, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190882, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190883, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190884, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190885, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190886, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190887, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190888, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190889, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190890, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190891, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190892, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190893, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190894, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190895, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190896, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190897, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190898, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190899, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190900, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190901, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190902, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190903, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190904, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190905, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190906, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190907, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190908, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190909, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190910, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190911, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190912, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190913, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190914, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190915, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190916, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190917, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190918, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190919, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190920, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190921, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190922, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190923, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190924, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190925, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190926, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190927, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190928, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190929, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190930, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190931, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190932, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190933, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190934, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190935, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190936, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190937, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190938, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190939, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190940, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190941, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190942, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190943, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190944, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190945, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190946, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190947, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190948, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190949, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190950, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190951, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190952, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190953, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190954, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190955, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190956, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190957, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190958, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190959, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190960, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190961, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190962, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190963, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190964, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190965, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190966, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190967, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190968, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190969, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190970, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190971, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190972, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190973, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190974, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190975, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190976, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190977, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190978, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190979, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190980, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190981, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190982, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190983, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190984, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190985, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190986, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190987, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190988, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190989, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190990, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190991, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190992, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190993, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190994, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190995, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190996, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190997, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(190998, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(190999, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191000, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191001, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191002, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191003, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191004, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191005, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191006, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191007, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191008, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191009, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191010, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191011, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191012, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191013, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191014, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191015, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191016, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191017, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191018, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191019, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191020, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191021, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191022, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191023, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191024, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191025, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191026, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191027, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191028, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191029, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191030, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191031, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191032, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191033, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191034, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191035, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191036, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191037, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191038, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191039, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191040, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191041, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191042, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191043, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191044, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191045, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191046, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191047, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191048, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191049, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191050, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191051, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191052, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191053, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191054, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191055, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191056, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191057, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191058, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191059, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191060, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191061, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191062, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191063, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191064, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191065, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191066, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191067, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191068, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191069, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191070, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191071, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191072, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191073, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191074, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191075, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191076, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191077, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191078, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191079, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191080, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191081, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191082, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191083, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191084, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191085, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191086, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191087, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191088, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191089, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191090, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191091, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191092, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191093, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191094, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191095, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191096, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191097, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191098, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191099, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191100, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191101, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191102, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191103, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191104, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191105, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191106, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191107, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191108, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191109, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191110, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191111, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191112, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191113, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191114, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191115, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191116, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191117, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191118, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191119, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191120, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191121, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191122, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191123, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191124, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191125, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191126, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191127, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191128, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191129, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191130, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191131, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191132, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191133, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191134, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191135, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191136, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191137, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191138, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191139, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191140, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191141, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191142, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191143, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191144, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191145, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191146, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191147, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191148, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191149, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191150, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191151, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191152, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191153, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191154, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191155, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191156, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191157, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191158, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191159, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191160, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191161, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191162, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191163, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191164, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191165, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191166, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191167, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191168, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191169, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191170, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191171, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191172, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191173, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191174, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191175, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191176, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191177, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191178, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191179, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191180, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191181, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191182, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191183, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191184, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191185, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191186, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191187, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191188, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191189, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191190, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191191, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191192, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191193, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191194, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191195, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191196, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191197, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191198, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191199, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191200, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191201, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191202, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191203, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191204, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191205, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191206, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191207, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191208, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191209, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191210, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191211, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191212, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191213, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191214, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191215, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191216, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191217, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191218, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191219, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191220, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191221, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191222, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191223, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191224, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191225, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191226, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191227, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191228, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191229, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191230, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191231, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191232, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191233, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191234, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191235, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191236, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191237, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191238, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191239, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191240, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191241, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191242, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191243, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191244, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191245, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191246, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191247, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191248, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191249, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191250, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191251, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191252, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191253, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191254, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191255, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191256, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191257, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191258, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191259, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191260, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191261, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191262, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191263, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191264, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191265, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191266, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191267, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191268, 'HP:0034098', 'Anti-phosphatidyl glycerol antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191269, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191270, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191271, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191272, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191273, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191274, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191275, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191276, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191277, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191278, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191279, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191280, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191281, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191282, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191283, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191284, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191285, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191286, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191287, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191288, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191289, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191290, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191291, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191292, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191293, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191294, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191295, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191296, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191297, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191298, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191299, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191300, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191301, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191302, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191303, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191304, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191305, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191306, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191307, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191308, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191309, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191310, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191311, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191312, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191313, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191314, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191315, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191316, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191317, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191318, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191319, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191320, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191321, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191322, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191323, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191324, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191325, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191326, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191327, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191328, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191329, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191330, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191331, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191332, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191333, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191334, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191335, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191336, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191337, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191338, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191339, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191340, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191341, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191342, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191343, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191344, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191345, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191346, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191347, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191348, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191349, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191350, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191351, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191352, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191353, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191354, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191355, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191356, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191357, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191358, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191359, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191360, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191361, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191362, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191363, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191364, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191365, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191366, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191367, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191368, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191369, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191370, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191371, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191372, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191373, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191374, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191375, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191376, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191377, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191378, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191379, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191380, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191381, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191382, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191383, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191384, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191385, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191386, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191387, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191388, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191389, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191390, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191391, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191392, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191393, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191394, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191395, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191396, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191397, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191398, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191399, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191400, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191401, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191402, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191403, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191404, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191405, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191406, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191407, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191408, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191409, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191410, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191411, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191412, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191413, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191414, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191415, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191416, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191417, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191418, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191419, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191420, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191421, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191422, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191423, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191424, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191425, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191426, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191427, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191428, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191429, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191430, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191431, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191432, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191433, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191434, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191435, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191436, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191437, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191438, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191439, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191440, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191441, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191442, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191443, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191444, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191445, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191446, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191447, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191448, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191449, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191450, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191451, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191452, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191453, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191454, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191455, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191456, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191457, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191458, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191459, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191460, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191461, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191462, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191463, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191464, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191465, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191466, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191467, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191468, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191469, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191470, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191471, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191472, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191473, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191474, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191475, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191476, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191477, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191478, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191479, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191480, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191481, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191482, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191483, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191484, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191485, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191486, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191487, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191488, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191489, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191490, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191491, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191492, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191493, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191494, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191495, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191496, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191497, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191498, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191499, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191500, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191501, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191502, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191503, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191504, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191505, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191506, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191507, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191508, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191509, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191510, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191511, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191512, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191513, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191514, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191515, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191516, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191517, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191518, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191519, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191520, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191521, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191522, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191523, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191524, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191525, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191526, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191527, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191528, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191529, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191530, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191531, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191532, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191533, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191534, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191535, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(191536, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(191537, 'HP:4000013', 'Anti-desmoglein-1 antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
